Perry M, Reifenberger G. Histological classification and molecular genetics of meningiomas. Lancet Neurol. 2006;1045–1045.
2.
Bj M. Villano jL. Update on meningiomas. Oncologist. 2001;(11):1604–13.
3.
David N Louis H, Ohgaki O, Wiestler W, Cavenee. WHO classification of tumors of the central nervous system. 2007;
4.
Manivel J, Jm S. Pathology of meningiomas. Clinicopathologi study of potentially aggressive variant of meningiomas. aM j surg Pathol. 1995;493–505.
5.
Expression of extracellular matrix degrading proteins in classic,atypical and anaplastic meningiomas. Pathology-research and practice. 2006;365–72.
6.
Glondu M, Coopman P, Laurent-Matha V, Garcia M, H. Liaudet Coopman E. a mutated Cathepsin d devoid of its atalytic activity stimulates the growth of cancer cells. Oncogene. 2001;6920–9.
7.
Glondu M, Liaudet-Coopman E, Platet N, Garcia H, M. down-regulation of cathepsin d expression by antisense gene transfer inhibits tumor growth and experimental lung metastasis of human breast cancer ells. Oncogene. 2002;5127–34.
8.
Berchem G, Glondu M, Gleizes M, Brouillet Jp, Vignon F, Garcia M, et al. Cathepsin d affects multiple tumor progression steps in vivo: proliferation, angiogenesis and apoptosis. Oncogene. 2001;5951–5.
9.
Louis, Bw, Budka H. Meningiomas: Pathology and genetics of tumors of the nervous system. 2000;176–84.
10.
Redecker B, Heckendorf B, Grosch H. Molecular organization of the human Cathepsin d gene. dNa Cell Biol. 1991;423–341.
11.
Rochefort H, Garcia M, Glondu M. Cathepsin d in breast cancer: mehanism and linical applications: a 1999 overwiew. Clin Chim acta. 2000;157–70.
12.
Frohlich E, Morhle B, M. activity expression and transcription rate of Cathepsins B, d, H and L in cutaneous malignant melanoma. Cancer. 2001;972–82.
13.
Nissen a. expression of adhesion factors and degrading proteins in primary and secondary glioblastoma and their precursor tumors. Invasion Metastasis. 1998;27–284.
14.
Patholres Pract. 2000;710–1.
15.
Sivaparvathi M, Chintala Sk. Expression of cathepsin d during the progression of human gliomas. Neurosci Lett. 1996;171–4.
16.
Warich M, Bossanyi V, P. Expression of cathepsin d in human astrocytic neoplasia. Gen diagnPathol. 1995;93–6.
17.
Robson Dk I, Dw R, Wa. Immunolocalization of cathepsin d in the human nervous system and central nervous system neoplasm. Neuropathil appl Neuro-biol. 1990;39–44.
18.
Gottschalk J, Goebel G. Influence of preoperative dexamethason therapy on proliferating cell nuclear antigen (PCNa) expression in comparison to other parameters in meningiomas. Histol Histopathol. 1992;653–61.
19.
Koehorst, Med, Van Der Kallen, Cjh. Progesterone receptor synthesis in human meningiomas: relation to the estrogen-induced proteins ps2 and cathepsin d and influence of epidermal growth factor, forskolin and phorbol ester in vitro. Int j Biol Markers. 1998;16–23.
20.
Cavailles V, Garcia P, M. Estrogenes and growth factors induce the mrNa of the 52 K-procathepsin d secreted by breast cancer cells. Nucleic acid res. 1998;1903–19.
21.
Ma B, Verheijen F, Jacobs J. Occurrence, regulation and significance of progesterone reeptors in human meningioma. steroids. 2000;795–800.
22.
Castilla Ae, Prayson Ra C, Mc, Cohen L. Immunohistochemical expression od Cathepsin d in Meningiomas. am j Clin Pathol. 2003;123–8.
Citation
Copyright
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.
